Clinical Trial Update: Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

View source ↗

Summary

This clinical trial update examines serum Dickkopf-4 as a biomarker for diagnosing and guiding treatment of gastrointestinal stromal tumor (GIST).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Snippet

Sponsor: RenJi Hospital | Conditions: Gastrointestinal Stromal Tumor | Status: UNKNOWN